Cohen K, Auld F, Demers L, Catchlove R
J Nerv Ment Dis. 1985 Oct;173(10):621-7. doi: 10.1097/00005053-198510000-00008.
The aim of this study was to examine whether the Archetypal9 Test (AT9) could meet the need for a valid and reliable test with which to measure the alexithymic trait cluster. Participants in this study included 61 patients drawn from pain clinics in Montreal (Royal Victoria Hospital) and Detroit (Henry Ford Hospital) and 30 patients undergoing minor surgery at the Royal Victoria Hospital in Montreal. All 91 subjects took both the AT9 Test and the Clarke Vocabulary Scale. The results of the attempts at validation reveal that the objectively scored AT9 Test (SAT9) is a highly internally consistent instrument, that it has demonstrated construct validity, and that it can significantly discriminate between patient groups (pain patients and medical patients). The SAT9 is positively related to age, inversely related to occupational level, and uncorrelated with IQ (as measured by the Clarke Vocabulary Scale). The authors concluded that thus far, the SAT9 has proven to be a valid instrument which can be used to measure a central feature of alexithymia.
本研究的目的是检验原型9测试（AT9）是否能够满足对一种有效且可靠的测试的需求，以便测量述情障碍特质群。本研究的参与者包括从蒙特利尔（皇家维多利亚医院）和底特律（亨利·福特医院）的疼痛诊所选取的61名患者，以及在蒙特利尔皇家维多利亚医院接受小手术的30名患者。所有91名受试者均进行了AT9测试和克拉克词汇量表测试。验证尝试的结果表明，客观评分的AT9测试（SAT9）是一种高度内部一致的工具，它已证明具有结构效度，并且能够显著区分患者组（疼痛患者和内科患者）。SAT9与年龄呈正相关，与职业水平呈负相关，与智商（通过克拉克词汇量表测量）无关。作者得出结论，到目前为止，SAT9已被证明是一种可用于测量述情障碍核心特征的有效工具。
